This review focuses on tumors arising outside the central nervous system and their bidirectional interactions with peripheral nerves, summarizing the current evidence on the molecular mechanisms underlying these reciprocal interactions.
Abstract
Neural–tumor crosstalk has emerged as a critical frontier in tumor microenvironment research. Central to this field is the dynamic, bidirectional regulatory network between the nervous system and tumor cells that orchestrates malignant progression. This review focuses on tumors arising outside the central nervous system and their bidirectional interactions with peripheral nerves, summarizing the current evidence on the molecular mechanisms underlying these reciprocal interactions. We first examine how neural components modulate tumorigenesis through the release of neuroactive molecules and proteins that activate oncogenic signaling pathways. In particular, neurons and Schwann cells can transmit protumorigenic signals via paracrine signaling, exosome-mediated communication, and the formation of functional neuroneoplastic synapses. Conversely, tumors can actively “hijack” and remodel their neural architecture to promote axonogenesis and neural infiltration while contributing to complications such as cancer pain and paraneoplastic neurological syndromes. We further highlight the pivotal role of neural signaling in reshaping the tumor microenvironment across three interconnected dimensions: the spatial dimension (neural niches), the signaling dimension (bidirectional communication mediated by neuroactive molecules), and the functional dimension (immunometabolic reprogramming). Together, these processes contribute to tumor progression and immune evasion. Building on these insights, therapeutic strategies targeting the neural–tumor interface have shown promising clinical potential. Further characterization of these regulatory networks may identify context-specific drivers of tumorigenesis and progression and inform the development of novel therapeutics targeting neural pathways.
It is proposed that the brain-tumor axis represents an emerging integrative hallmark of cancer, defined by the context-dependent duality of neural signaling, whereby identical pathways elicit opposing pro- or anti-tumorigenic effects contingent on tumor type, disease stage, and microenvironmental context.
Yu-Xin Liu, Chun-Yuan Guo, Xing Wang et al.· Cancer Treatment and Researc...· 0 citations
A hierarchical neuro–tumor interaction framework is proposed that provides an integrated conceptual basis for understanding the complexity and context dependency of neural regulation in cancer biology.
Current knowledge of neuronal regulation in cancer across three layers is summarized: direct synaptic communication, neuron-derived paracrine signaling, and neuroimmune modulation, and a translational framework is proposed to bridge basic discoveries with clinical application.
Shiyi Liu, C. Cao, Chang Zhu et al.· Biochimica et biophysica act...· 0 citations
Classic oncological models have largely restricted cancer pathogenesis to autonomous genetic mutations within localized cells. Current research, however, reframes solid tumors as structurally integrated “pseudo‐organs” that rely on host neural networks for survival. This review examines the reciprocal signaling network...
This review synthesizes how nerves and brain activity directly influence tumour growth across multiple diseases—including gliomas, small cell lung cancer, breast cancer, pancreatic cancer, and prostate cancer—and how these neural signals converge with metabolic and drug-resistance pathways that limit the efficacy of co...
F. Petrelli, A. Callea, A. Ghidini et al.· Medical Oncology· 0 citations
The emerging field of cancer neuroscience has revealed the nervous system as a dynamic regulator of tumors and the tumor microenvironment. Neural activity influences tumor progression through electrical signaling, neurotransmitter and neuropeptide release, and interactions with immune cells. The direction and magnitude...
Xin-Bo Yu, Gui-Lin Xiang, Han Wang et al.· Journal of Controlled Releas...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.